Year: 2024

United-Guardian Reports Increased Third Quarter Earnings

Written by Customer Service on November 8, 2024. Posted in Earnings Releases And Operating Results.

HAUPPAUGE, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) — United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the third quarter and the first nine months of 2024. Sales for the nine-month period ended September 30th increased from $8,278,141 in 2023 to $9,705,262 in 2024 and net income increased from $1,843,931 ($0.40 per share) to $2,747,151 ($0.60 per share) for the same period. The third quarter remained steady with sales of $3,057,518 in 2023 and $3,060,113 in 2024, while net income increased from $626,756 ($0.14 per share) to $865,484 ($0.19 per share). Donna Vigilante, President of United-Guardian, stated, “We are pleased to announce that sales and earnings increased in the third quarter and for the first nine months of 2024 compared with the same periods in 2023. We continue to have strong sales of our cosmetic...

Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates

Written by Customer Service on November 8, 2024. Posted in Earnings Releases And Operating Results.

Continue to advance hypoimmune technology in three trials across five indications in type 1 diabetes, B-cell mediated autoimmune diseases, and oncology Enrolling patients in the investigator-sponsored trial with hypoimmune-modified primary islet cells, GLEAM trial for SC291 in B-cell mediated autoimmune diseases, and VIVID trial for SC262 in relapsed/refractory B-cell malignancies; expect data from these studies in 2024 and/or 2025 Announced increased focus on type 1 diabetes and B-cell mediated autoimmune diseases  Cash position of $199.0 million with expected cash runway into 2026 SEATTLE, Nov. 08, 2024 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today reported financial results and business highlights for the third quarter 2024. “Early...

Medigene Presents Unique Approach for Use of Optimal T Cell Receptors in TCR-Guided Modalities at Cell 2024

Written by Customer Service on November 8, 2024. Posted in Public Companies.

Members of Medigene management as expert speakers, Prof. Dolores Schendel, Chief Scientific Officer and Kirsty Crame, MD, Vice President, Clinical Strategy & Development Presentations and seminars highlighted Medigene’s proprietary End-to-End Platform for generation of extraordinary T cell receptors for application in various modalities and overview of the lead TCR-T therapy program MDG1015Planegg/Martinsried, November 8, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, highlighted recent advances in its proprietary End-to-End Platform to create optimal safe, sensitive, and specific (3S) T cell receptors that can be applied in various modalities, including therapies...

VEON Group Reaffirms Commitment to Strengthen Pakistan’s Digital Infrastructure in Meeting with Prime Minister

Written by Customer Service on November 8, 2024. Posted in Public Companies.

A VEON delegation led by Chairman and Founder Augie Fabela, Group CEO Kaan Terzioglu and Jazz CEO Aamir Ibrahim visited Prime Minister of Pakistan Shehbaz Sharif today in Islamabad.A VEON delegation led by Chairman and Founder Augie Fabela, Group CEO Kaan Terzioglu and Jazz CEO Aamir Ibrahim visited Prime Minister of Pakistan Shehbaz Sharif today in Islamabad. Islamabad, 8 November 2024 – VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON), a global digital operator, is pleased to announce that a VEON delegation led by VEON Chairman and Founder Augie Fabela, VEON Group CEO Kaan Terzioglu and Jazz CEO Aamir Ibrahim visited Prime Minister of Pakistan Shehbaz Sharif today in Islamabad, to discuss the advancement of the country’s digital landscape. The Prime Minister commended Jazz’s role in driving digital transformation...

LITGRID AB publishes results for the 9 months of 2024

Written by Customer Service on November 8, 2024. Posted in Public Companies.

LITGRID AB, company code 302564383, registered office address Karlo Gustavo Emilio Manerheimo str. 8, Vilnius, Lithuania, is publishing results of the Company for the nine months of 2024. Key financial indicators for 9 months of 2024:Main financial results 9 months of 2024 9 months of 2023Revenue, EUR million 279.6 274.9EBITDA, EUR million 48.6 62.1Net profit, EUR million 31.7 43.3ROE (for the last 12 months), percents 16.3 19.5Adjusted* EBITDA, EUR million 37.3 29.6Adjusted* NET profit, EUR million 22.1 15.6Adjusted* ROE (for the last 12 months), percents 12.6 9.2*The adjustment of profitability ratios is made due to temporary regulatory deviations from the regulated profitability approved by the National Energy Regulatory Council (NERC). The calculation of the adjusted ratios shall take into account the adjustment...

Clover Leaf Capital Corp. Announces Termination of Merger Agreement, Cancellation of Special Meeting and its Intention to Liquidate

Written by Customer Service on November 8, 2024. Posted in Mergers And Acquisitions.

MIAMI, FL, Nov. 08, 2024 (GLOBE NEWSWIRE) — Clover Leaf Capital Corp. (OTC: CLOE) (the “Company” or “Clover Leaf”), announced today that Clover Leaf and Kustom Entertainment, Inc. (“Kustom Entertainment”) have mutually agreed to terminate their previously announced Agreement and Plan of Merger (the “Merger Agreement”), effective as of November 7, 2024 by entering into a mutual termination and release agreement (the “Termination and Release Agreement”) among Clover Leaf, CL Merger Sub, Inc., Yntegra Capital Investments LLC, Kustom Entertainment and Digital Ally, Inc. The Merger Agreement was dated as of June 1, 2023, as amended on June 24, 2024 and on September 3, 2024. The Termination and Release Agreement terminates the Merger Agreement, which will be described in a Current Report on Form 8-K to be filed by Clover Leaf. In view...

GCM Grosvenor Reports Third Quarter 2024 Earnings Results, with Year-to-Date Fundraising Increasing 34%, and Year-to-Date GAAP Net Income, Fee-Related Earnings and Adjusted Net Income Increasing 16%, 18% and 24%, Respectively, Year-Over-Year

Written by Customer Service on November 8, 2024. Posted in Earnings Releases And Operating Results.

CHICAGO, Nov. 08, 2024 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, today reported its results for the third quarter 2024. GCM Grosvenor issued a detailed presentation of its third quarter ending September 30, 2024 results to the Public Shareholders section of GCM Grosvenor’s website at https://www.gcmgrosvenor.com/shareholder-events. Conference Call A conference call to discuss GCM Grosvenor’s financial results will be held today, Friday, November 8, 2024, at 10:00 a.m. ET. The call will be accessible via public webcast from the Public Shareholders section of GCM Grosvenor’s website at https://www.gcmgrosvenor.com/shareholder-events, and a replay of the live broadcast will be available on the website soon after the call’s completion. The call can also be accessed by...

AMC Networks Inc. Reports Third Quarter 2024 Results

Written by Customer Service on November 8, 2024. Posted in Earnings Releases And Operating Results.

NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) — AMC Networks Inc. (“AMC Networks” or the “Company”) (NASDAQ: AMCX) today reported financial results for the third quarter ended September 30, 2024. Chief Executive Officer Kristin Dolan said: “As we manage this business within a complex and changing environment, we remain focused on our key strategic pillars – programming, partnerships and profitability. During the quarter, we made significant advancements across all three areas. We have generated $293 million of free cash flow year to date and are well on our way to delivering our stated goal of approximately half a billion dollars in cumulative free cash over two years. We also entered into new and enhanced partnerships with major companies like Charter, Netflix, Amazon and others which are driving...

Infortar acquired 100% shareholding in existing subsidiary

Written by Customer Service on November 8, 2024. Posted in Public Companies.

In the course of the intra-group reorganization of AS Infortar, on 8 November 2024, AS Tallink Grupp transferred 34,000 shares of AS Tallink Takso with a nominal value of 6.3 euros, representing 34% of the share capital, to AS Infortar. Following the transaction, AS Infortar will hold 100% of the shares in AS Tallink Takso. The transaction is not treated as a transaction beyond everyday economic activities or a transaction of a significant importance. Transaction is between related parties but does not have a significant impact on the activities of AS Infortar or AS Tallink Grupp. Aktsiaselts Infortar operates in seven countries, the company’s main fields of activity are maritime transport, energy and real estate. Aktsiaselts Infortar owns a 68.47% stake in Aktsiaselts Tallink Grupp, a 100% stake in AS Eesti Gaas and a versatile...

AS Infortar acquires 100% shareholding in AS Tallink Takso

Written by Customer Service on November 8, 2024. Posted in Public Companies.

In the course of the intra-group reorganisation of AS Infortar, on 7 November 2024, AS Tallink Grupp transferred 34,000 shares of AS Tallink Takso with a nominal value of 6.3 euros, representing 34% of the share capital, to AS Infortar. Following the transaction, AS Infortar will hold 100% of the shares in AS Tallink Takso. The transaction is not treated as a transaction beyond everyday economic activities or a transaction of a significant importance. Transaction is between related parties but does not have a significant impact on the activities of AS Infortar or AS Tallink Grupp.Anneli SimmInvestorsuhete juht AS Tallink GruppSadama 510111 TallinnPhone: +372 56157170E-mail Anneli.simm@tallink.ee

Year: 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals